Scientific Sessions

• Neurobiology of Addiction and Brain Reward Pathways
• Evidence-Based Treatments in Addiction Medicine
• Dual Diagnosis: Addiction and Co-Occurring Psychiatric Disorders
• Behavioral Therapies and Psychosocial Interventions
• Recovery Models, Relapse Prevention, and Long-Term Care
• Public Health Approaches, Policy, and Community-Based Recovery

Addiction Medicine and Recovery Science is a core scientific session that explores substance use disorders as complex, chronic brain and behavioral conditions influenced by biological, psychological, and social factors. This session examines the neurobiological mechanisms underlying addiction, including reward circuitry, neurotransmitter dysregulation, genetic vulnerability, and stress-related pathways. Participants will gain insights into how substances such as alcohol, opioids, stimulants, and emerging addictive behaviors alter brain function and decision-making. The session integrates current research on diagnostic frameworks, biomarkers, and risk stratification, supporting early identification and precision-based treatment planning. As a key component of an international addiction and psychiatry conference, this track bridges neuroscience and clinical practice to improve patient outcomes across diverse populations.

The session at addiction and psychiatry conferences further emphasizes evidence-based treatment strategies, including medication-assisted treatment (MAT), cognitive behavioral therapy, motivational interviewing, and trauma-informed care. Special focus is placed on dual diagnosis, where addiction coexists with psychiatric disorders such as depression, anxiety, bipolar disorder, and schizophrenia. Experts will discuss integrated care models that align mental health and addiction services, reducing relapse rates and improving functional recovery. Recovery science topics include relapse prevention, peer support systems, digital therapeutics, and long-term recovery monitoring. Public health perspectives—such as harm reduction, policy development, stigma reduction, and community-based interventions—are also explored. Designed for clinicians, researchers, psychologists, and policymakers attending leading psychiatry and addiction conferences, this session highlights translational research and scalable solutions that advance recovery-oriented systems of care globally.

Key Highlights

• Latest research on neurobiology and genetics of addiction
• Clinical updates on medication-assisted and behavioral treatments
• Integrated management of addiction with mental health disorders
• Recovery-oriented care models and relapse prevention strategies
• Public health, policy, and harm-reduction approaches

Why This Session Is Important?

Addiction Medicine and Recovery Science is essential for advancing evidence-based, compassionate, and integrated care for substance use disorders. By combining neuroscience, psychiatry, and recovery research, this session equips professionals with practical tools to address addiction as a treatable medical condition, reduce stigma, and improve long-term recovery outcomes at both individual and population levels.